25 related articles for article (PubMed ID: 19200741)
1. A Simple and Easily Implemented Method for the Regioselective Introduction of Deuterium into Azolo[1,5-
Danagulyan GG; Panosyan HA; Gharibyan VK; Hasratyan AH
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985841
[TBL] [Abstract][Full Text] [Related]
2. Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-
Hammouda MM; Gaffer HE; Elattar KM
RSC Med Chem; 2022 Oct; 13(10):1150-1196. PubMed ID: 36325400
[TBL] [Abstract][Full Text] [Related]
3. Effect of CDCA5 on Proliferation and Metastasis of Triple Negative Breast Cancer Cells under shRNA Interference Technology.
Li Y; Peng W; Deng Y; Heng J; Yang Y; Jin X; Li J; Li T
J Oncol; 2022; 2022():9038230. PubMed ID: 35726220
[TBL] [Abstract][Full Text] [Related]
4. p21 in Cancer Research.
Shamloo B; Usluer S
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31416295
[TBL] [Abstract][Full Text] [Related]
5. A facile, regioselective synthesis of novel 3-(N-phenylcarboxamide)pyrazolo[1,5-a]pyrimidine analogs in the presence of KHSO4 in aqueous media assisted by ultrasound and their antibacterial activities.
Kaping S; Boiss I; Singha LI; Helissey P; Vishwakarma JN
Mol Divers; 2016 May; 20(2):379-90. PubMed ID: 26511367
[TBL] [Abstract][Full Text] [Related]
6. A facile environment-friendly one-pot two-step regioselective synthetic strategy for 3,7-diarylpyrazolo[1,5-a]pyrimidines related to zaleplon and 3,6-diarylpyrazolo[1,5-a]pyrimidine-7-amines assisted by KHSO₄ in aqueous media.
Devi AS; Kaping S; Vishwakarma JN
Mol Divers; 2015 Nov; 19(4):759-71. PubMed ID: 26016724
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells.
Li HF; Keeton A; Vitolo M; Maddox C; Rasmussen L; Hobrath J; White EL; Park BH; Piazza GA; Kim JS; Waldman T
J Biomol Screen; 2011 Apr; 16(4):383-93. PubMed ID: 21335596
[TBL] [Abstract][Full Text] [Related]
8. Medicinal attributes of pyrazolo[3,4-d]pyrimidines: a review.
Chauhan M; Kumar R
Bioorg Med Chem; 2013 Sep; 21(18):5657-68. PubMed ID: 23932070
[TBL] [Abstract][Full Text] [Related]
9. Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.
Asati V; Anant A; Patel P; Kaur K; Gupta GD
Eur J Med Chem; 2021 Dec; 225():113781. PubMed ID: 34438126
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agents.
Wang YD; Honores E; Wu B; Johnson S; Powell D; Miranda M; McGinnis JP; Discafani C; Rabindran SK; Cheng W; Krishnamurthy G
Bioorg Med Chem; 2009 Mar; 17(5):2091-100. PubMed ID: 19200741
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel anti-proliferative agents: parallel synthesis for lead optimization of amide region.
Gopalsamy A; Yang H; Ellingboe JW; Tsou HR; Zhang N; Honores E; Powell D; Miranda M; McGinnis JP; Rabindran SK
Bioorg Med Chem Lett; 2005 Mar; 15(6):1591-4. PubMed ID: 15745803
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases.
Markwalder JA; Arnone MR; Benfield PA; Boisclair M; Burton CR; Chang CH; Cox SS; Czerniak PM; Dean CL; Doleniak D; Grafstrom R; Harrison BA; Kaltenbach RF; Nugiel DA; Rossi KA; Sherk SR; Sisk LM; Stouten P; Trainor GL; Worland P; Seitz SP
J Med Chem; 2004 Nov; 47(24):5894-911. PubMed ID: 15537345
[TBL] [Abstract][Full Text] [Related]
13. Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel antiproliferative agents: exploration of core and headpiece structure-activity relationships.
Powell D; Gopalsamy A; Wang YD; Zhang N; Miranda M; McGinnis JP; Rabindran SK
Bioorg Med Chem Lett; 2007 Mar; 17(6):1641-5. PubMed ID: 17275298
[TBL] [Abstract][Full Text] [Related]
14. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation and structure-activity relationships. Part 2.
Horiuchi T; Nagata M; Kitagawa M; Akahane K; Uoto K
Bioorg Med Chem; 2009 Dec; 17(23):7850-60. PubMed ID: 19889545
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
